Lab-scale Preparation of Recombinant Human Insulin-like Growth Factor-1 in Escherichia coli and its Potential Safety on Normal Human Lung Cell Line

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Mohamed O.A.; Samir S.; Omar H.; Hassan E.A.; Abdelazeem E.

Journal: Recent Patents on Biotechnology

Publisher: Bentham Science Publishers

Publication Date: September 2022

Volume / Issue: Volume 16 / Issue 3

Pages: 266–280

ISSN: 18722083

DOI: 10.2174/1872208316666220412105822

Scopus: View on Scopus

PubMed: 35418294

Document Type: Article


Authors and Affiliations

Mohamed O.A., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Samir S., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Omar H., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Hassan E.A., Biochemistry Department, Faculty of Science, Ain-Shams University, Cairo, Egypt; Abdelazeem E., Biochemistry Department, Faculty of Science, Ain-Shams University, Cairo, Egypt


Abstract

Background: Insulin-like growth factor-1 (IGF-1) is structurally similar to insulin and acts as an endocrine hormone secreted by the liver. Objective: Production of recombinant human IGF-1 (rhIGF-1) in Escherichia coli (E.coli) and evaluation of its proliferation stimulatory activity. Methods: hIGF-1 gene cloned into pBSK (+) simple vector was transformed into TOP 10 chemically competent cells of E. coli. Polymerase chain reaction (PCR) was achieved using specific hIGF-1 gene primers to confirm the successful transformation. To express the rhIGF-1 in E. coli (Rosetta (DE3) pLysS); the hIGF-1 gene was cloned into the pET-15b expression vector and then the recombinant pET-15b/IGF-1 vector was transformed into a chemically prepared competent expression bacterial cells; Rosetta (DE3) pLysS. The rhIGF-1 was expressed as insoluble aggregates called inclusion bodies (IBs) using a 2 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) inducer. IBs were solubilized in a denatured form using 6 M guanidinium hydrochloride (GdmCl), followed by in vitro protein refold-ing using the rapid dilution method. The refolded hIGF-1 was purified using the HiTrap-ANX anion exchange column. Western blot and ELISA using rabbit polyvalent anti-hIGF-1 were performed to confirm the protein antigenic identity. Cell proliferation activity of rhIGF-1 was testified on normal human lung cell line (WI-38). Results: rhIGF-1 was purified from the HiTrap-ANX column at a concentration of 300 µg/ml. Western blot showed a single 7.6 kDa band obtained in the induced Rosetta (DE3) pLYsS. ELISA confirmed the molecular identity of the rhIGF-1 epitope, the concentration of purified rhIGF-1 obtained from the ELISA standard curve using rhIGF-1 reference protein as a standard was 300 µg/ml, and activity on WI-38 cells was 2604.17I U/mg. Conclusion: Biologically active native rhIGF-1 protein was successfully expressed. Pa-tents related to the preparation of IGF-1 were mentioned along the text. © 2022 Bentham Science Publishers.


Keywords

ELISA; Escherichia coli; hIGF-1; human lung cell line; proliferation assay; recombinant expression; Western blot; Animals; Cell Line; Humans; Insulin-Like Growth Factor I; Irritable Bowel Syndrome; Lung; Patents as Topic; Rabbits; Recombinant Proteins; Antigens; Biological organs; Cell culture; Cell proliferation; Cloning; Genes; Insulin; Polymerase chain reaction; Purification; growth factor; recombinant human insulin; recombinant somatomedin C; somatomedin C; recombinant protein; Cell lines; Human lung cells; Insulin-like growth factor-1; Rosetta; Western blots; anion exchange; anion exchange chromatography; antibacterial activity; Article; bacterial cell; calibration; cell count; cell inclusion; cell proliferation assay; cross linking; denaturation; dilution; enzyme activity; enzyme linked immunosorbent assay; expression vector; gene amplification; gene expression; human; human cell; lung cell line; lymphocyte; molecular weight; MTT assay; nonhuman; plasmid; polyacrylamide gel electrophoresis; protein denaturation; protein expression; protein purification; Western blotting; WI-38 cell line; animal; genetics; irritable colon; Leporidae; metabolism; patent; Proteins


Citation Information

Scopus Citations: 6


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]